Sex differences in neonatal outcomes following prenatal opioid exposure

Nethra K Madurai1, Lauren L Jantzie1,2,3,4, Elizabeth Yen5,6,7

  • 1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

PubMed

Insights

Prenatal opioid exposure impacts neonates, with biological sex influencing outcomes. Research is needed to understand sex-specific effects on infant brain development and health.

Area of Science:

  • Neonatal outcomes
  • Neuroscience
  • Public Health

Background:

  • The opioid epidemic poses a significant public health challenge, affecting pregnant individuals and infants.
  • Understanding the impact of opioids on the developing brain during pregnancy and postnatally is crucial.
  • Biological sex is a key factor in physiological processes and may influence neonatal outcomes in infants with opioid exposure.

Purpose of the Study:

  • To review current literature on the effects of biological sex on neonatal outcomes following prenatal opioid exposure.
  • To highlight the importance of considering sex as a biological variable in neonatal research.
  • To inform strategies for improving the health of infants affected by prenatal opioid exposure.

Main Methods:

  • Literature review of studies investigating sex differences in neonatal outcomes related to prenatal opioid exposure.
  • Analysis of emerging clinical data on sex-specific effects in infants.
  • Synthesis of findings on gene expression, feeding regulation, reward pathways, and white matter injury.

Main Results:

  • Sex differences in opioid use disorder are established in adults but less understood in neonates.
  • Emerging data suggest sex-specific effects in infants, including impacts on genes for feeding regulation and reward pathways.
  • Female infants exposed to opioids prenatally may have increased susceptibility to white matter injury.

Conclusions:

  • Biological sex significantly influences neonatal outcomes following prenatal opioid exposure.
  • Further research into sex-specific effects is critical for targeted interventions and improved infant health.
  • Understanding these sex differences is paramount for addressing the long-term health of individuals affected by the opioid epidemic.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
244
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614